Haemonetics to relocate headquarters to Boston
Haemonetics Corporation announced that the company will be relocating its global headquarters to downtown Boston from its current location in Braintree, Massachusetts. Haemonetics' new headquarters will occupy over 62,000 square feet at 125 Summer Street. Haemonetics announced plans to move its global headquarters to 125 Summer Street in downtown Boston. The new Boston headquarters will enable Haemonetics to right-size its footprint by selling its 40-acre campus in Braintree and will provide a sustainable, contemporary workplace, including dedicated lab and research space, to support the company's collaborative, performance-driven culture. The company's corporate and commercial teams will sit side by side with its research and development organizations. The company has signed a multiyear lease through 2032 and expects to have employees located across four floors of the 495,000 square foot LEED and Energy Star certified office tower. The move to the new location is expected to commence within the next year. With approximately 3,000 global employees, Haemonetics expects to move its more than 200 headquarters based positions to the new location.